文献速递乳腺癌放疗

乳腺癌风险适应性靶区勾画:争议与考量

Risk-Adapted Target Delineation for Breast Cancer: Controversies and Considerations.
PubMed 文献 · Pract Radiat Oncol · 2022-12-09

本文讨论基于CT计划和现代靶区勾画工具及大分割方案下乳腺癌放疗效率的提升,汇总淋巴结复发定位研究,分析两种淋巴结勾画指南的覆盖比例,并综述全胸壁是否纳入乳房切除术后/保乳术后临床靶区及乳房切除术后放疗中是否选择性使用bolus的文献,提出风险适应性勾画思路。

要点

  • 汇总定位研究比较两种淋巴结勾画指南对复发淋巴结的覆盖比例
  • 综述支持将真胸壁从乳房切除术后/保乳术后临床靶区中排除的文献
  • 综述支持乳房切除术后放疗中选择性(而非常规)使用bolus的文献

核心结论

  • 作者提出风险适应性勾画思路,兼顾复发风险与毒性,主张细致的靶区勾画而非一刀切做法。

研究设计与样本

  • 本文为综述与汇总分析,汇总已发表的淋巴结复发定位研究,并综述关于胸壁靶区与bolus使用的文献;原文未报告检索范围与样本量。

主要发现

  • 基于骨性标志的较大范围勾画指南在直觉上似乎更适合具有不利危险因素的患者。
  • 由于两种勾画方法无法直接比较,定位研究报道了复发淋巴结被这些勾画指南覆盖的比例。
  • 作者汇总分析了这些定位研究的结果。

临床怎么用

  • 作者建议采用风险适应性勾画,而非一刀切方式;作者支持将真胸壁从乳房切除术后/保乳术后临床靶区中排除,并支持乳房切除术后放疗中选择性(而非常规)使用bolus。

局限性

  • 原文指出两种勾画方法无法直接比较,因此相关定位研究仅报道复发淋巴结被指南覆盖的比例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The advent of computed tomography-based planning coupled with modern tools for target delineation and hypofractionated treatment schedules has increased efficiency and throughput for patients with breast cancer. While the benefit of adjuvant radiation therapy (RT) in reducing locoregional recurrences is established, disentangling local versus regional recurrence risks with modern treatment protocols has become an area of active research to de-escalate treatment. Delineation guidelines for nodal regions either attempt to replicate results of conventional RT techniques by translating bony landmarks to clinical target volumes or use landmarks based on the fact that lymphatic channels run along the vasculature. Because direct comparisons of both approaches are implausible, mapping studies of nodal recurrences have reported on the proportion of nodes included in these delineation guidelines, and larger, bony, landmark-based guidelines appear intuitively appealing for patients with unfavorable risk factors. A pooled analysis of these studies is reported here, along with literature supporting the exclusion of the true chest wall from postmastectomy/breast-conserving surgery clinical target volumes and the selective (versus routine) use of bolus during postmastectomy RT. The risk-adapted approach suggested here accounts for the risk of recurrence as well as toxicity and endorses nuanced target volume delineation rather than a one-size-fits-all approach.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ahmad I, Chufal KS, Miller AA, et al. Risk-Adapted Target Delineation for Breast Cancer: Controversies and Considerations. Pract Radiat Oncol. 2022. PMID: 36748210. doi:10.1016/j.prro.2022.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。